SCHEMBL13701433

SCHEMBL13701433

COc1ccc(-c2nc(/C=C/C(C)=O)co2)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
FDPS P14324 1/20 0.43
MAPT P10636 2/20 0.43
MIF P14174 1/20 0.43
NPC1 O15118 4/20 0.42
KDM4E B2RXH2 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
RAB9A P51151 2/20 0.42
HSD17B10 Q99714 1/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
TPH1 P17752 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ADORA3 P0DMS8 2/20 0.41
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640428 0.75 MAPK1 (0.47) MAPK1ALDH1A1HPGDMAPTMIF
Hydrochloric Acid SCHEMBL28034372 0.74 ALDH1A1 (0.56) MAPK1ALDH1A1HPGDMAPTNPC1
SCHEMBL4284461 0.73 KDM4E (0.44) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL4284454 0.73 KDM4E (0.44) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL4270515 0.72 ALDH1A1 (0.41) MAPK1ALDH1A1HPGDMAPTNPC1
SCHEMBL19194454 0.72 MAPT (0.44) MAPK1ALDH1A1HPGDMAPTNPC1
SCHEMBL5592936 0.72 MAPK1 (0.55) MAPK1ALDH1A1HPGDMAPTNPC1
SCHEMBL4278957 0.72 ALDH1A1 (0.60) MAPK1ALDH1A1HPGDMAPTNPC1
SCHEMBL13701423 0.72 ALDH1A1 (0.46) MAPK1ALDH1A1HPGDMAPTKDM4E
SCHEMBL4639472 0.71 ALDH1A1 (0.54) MAPK1ALDH1A1HPGDMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46792-E1 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-04-17 US disclosed
US-8637559-B2 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-01-28 US disclosed
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A MAPK1 453/4885ALDH1A1 234/4885HPGD 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.